Skip to content
★ Sign in to follow
金

金磊

Board Director
Director
佰仁医疗
Insider activity · 24 months1 buy0 salesCumulative net flow
Total declarations
6
Company
1
▲ Purchases (6 ops.)
€902k
▼ Sales (0 ops.)
—

Latest filing published 02 Jan 2025 for 佰仁医疗, €215k.

Filing timeline

BuySale
金磊

Insider track record

Disclosed buys
6
Disclosed sells
0
Signal history

Closed purchases

Market purchases
6
Positive at T+90
33%
Median T+90
-2.9%

Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 02 Jan 2025 · 677 days ago · €215k
    +3.1%
    Entry CN¥107.01 · Close at T+365 CN¥110.36
  • Filed 18 Nov 2024 · 722 days ago · €183k
    +8.3%
    Entry CN¥117.07 · Close at T+365 CN¥126.80
  • Filed 13 Jun 2022 · 1611 days ago · €170k
    -15.1%
    Entry CN¥122.09 · Close at T+365 CN¥103.67
  • Filed 07 Jun 2022 · 1617 days ago · €162k
    -18.5%
    Entry CN¥126.76 · Close at T+365 CN¥103.27
  • Filed 06 Jun 2022 · 1618 days ago · €66k
    -16.2%
    Entry CN¥125.58 · Close at T+365 CN¥105.18

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

金磊: trading record in brief

金磊 is a declared insider of 佰仁医疗 (board member), with filings sourced from SSE / SZSE (CSRC). We count 6 filings; the first trade dates from 31 May 2022 and the latest from 2 January 2025.

No open-market sale appears; the market trades are 6 purchases worth €902k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2025, the count stands at 1 purchase and no sales.

Half of the purchases are above €166k and half below. Across 6 purchases, this insider has always bought alone, with no colleague buying within 30 days. After 6 purchases with a full 90-day history, the hit rate stands at 33% and the median 90-day move at -2.9%. These figures describe past trades and do not predict future prices.

The newest entry dates from 2 January 2025: an open-market purchase of €215k, in 佰仁医疗. Half of the filings or more reach the SSE / SZSE (CSRC) feed on the day of the trade. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to 金磊

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total
  • ▲
    董事,高级管理人员,核心技术人员Executives佰仁医疗
    2M CNY9SSE
    15,200 shares23.9% of flowA股XSHGSSE:173000008396299330
    Canonical exit: 2 Apr 2025 (T+90)
  • ▲
    董事,高级管理人员,核心技术人员Executives佰仁医疗
    1M CNY9SSE
    12,000 shares20.3% of flowA股XSHGSSE:173000008276334940
    Canonical exit: 16 Feb 2025 (T+90)
  • ▲
    董事,高级管理人员,核心技术人员Executives佰仁医疗
    1M CNY9SSE
    10,000 shares18.9% of flowA股XSHGSSE:173000005588899000
    Canonical exit: 11 Sept 2022 (T+90)
  • ▲
    董事,高级管理人员,核心技术人员Executives佰仁医疗
    1M CNY9SSE
    9,100 shares18.0% of flowA股XSHGSSE:173000005578585860
    Canonical exit: 5 Sept 2022 (T+90)
  • ▲
    董事,高级管理人员,核心技术人员Executives佰仁医疗
    471,913 CNY8SSE
    3,716 shares7.3% of flowA股XSHGSSE:173000005573936450
    Canonical exit: 4 Sept 2022 (T+90)
  • ▲
    董事,高级管理人员,核心技术人员Executives佰仁医疗
    751,654 CNY8SSE
    6,084 shares11.6% of flowA股XSHGSSE:173000005560699740
    Canonical exit: 29 Aug 2022 (T+90)

6 of 6 declarations